Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Runlin Shi
Correction: Cisplatin-Induced Epigenetic Activation of miR-34a Sensitizes Bladder Cancer Cells to Chemotherapy
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Related publications
MiR-34a Chemosensitizes Bladder Cancer Cells to Cisplatin Treatment Regardless of P53-Rb Pathway Status
International Journal of Cancer
Cancer Research
Oncology
Blockage of Cisplatin-Induced Autophagy Sensitizes Cervical Cancer Cells to Cisplatin
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
MAPK/ERK Activation Sensitizes MKN-28 Cells to Cisplatin-Induced Apoptosis
Cancer Studies and Molecular Medicine - Open Journal
Simultaneous Activation and Inhibition of Autophagy Sensitizes Cancer Cells to Chemotherapy
Oncotarget
Oncology
Reactivation of Epigenetically Silenced miR-512 and miR-373 Sensitizes Lung Cancer Cells to Cisplatin and Restricts Tumor Growth
Cell Death and Differentiation
Cell Biology
Molecular Biology
Genistein Sensitizes Cancer Cells to Chemotherapy: Table 1.
Cancer Research
Cancer Research
Oncology
Silencing of CXCR4 Sensitizes Triple-Negative Breast Cancer Cells to Cisplatin
Oncotarget
Oncology
PARP Inhibition Sensitizes Colorectal Cancer-Initiating Cells to Chemotherapy
Stem Cells
Medicine
Molecular Medicine
Developmental Biology
Cell Biology
miR-152-3p Sensitizes Glioblastoma Cells Towards Cisplatin via Regulation of SOS1
OncoTargets and Therapy
Oncology
Pharmacology